OfloxacinFluoroquinolonesAnti-Infective AgentsCiprofloxacinMicrobial Sensitivity TestsLevofloxacinNorfloxacinQuinolonesDNA GyraseAza CompoundsAnti-Bacterial AgentsNaphthyridinesPefloxacinEnoxacinDNA Topoisomerase IVDrug Resistance, BacterialQuinolines4-QuinolonesDrug Resistance, MicrobialChemistry, PharmaceuticalDNA Topoisomerases, Type IIDrug Resistance, Multiple, BacterialStreptococcus pneumoniaeNalidixic AcidOxazinesTopoisomerase II InhibitorsDermatitis, PhototoxicFleroxacinAdministration, OralTabletsMycoplasma hominisDrug CompoundingExcipientsDelayed-Action PreparationsGram-Positive BacteriaGram-Negative BacteriaTyphoid FeverStaphylococcus aureusAntitubercular AgentsBacterial InfectionsGram-Negative Bacterial InfectionsMacrolidesDosage FormsRifampinEye Infections, BacterialPseudomonas aeruginosaEscherichia coliBiological AvailabilityMycobacterium tuberculosisMutationNeisseria gonorrhoeaeMycobacterium fortuitumPneumococcal InfectionsDrug Resistance, MultipleDNA, BacterialArea Under CurveDrug CarriersCapreomycinTrimethoprim-Sulfamethoxazole CombinationBacteria, AnaerobicSalmonella typhiEthambutolGonorrheaSerum Bactericidal TestTechnology, PharmaceuticalLeprostatic AgentsSalmonella paratyphi ATuberculosis, Multidrug-Resistantbeta-LactamsUrinary Tract InfectionsClostridium difficileCommunity-Acquired InfectionsParatyphoid FeverBacterial ProteinsEmulsionsDrug StabilityCephalosporinsBacteriaErythromycinDoxycyclineAnti-Infective Agents, UrinaryAdministration, TopicalNitrofurantoinColony Count, MicrobialEscherichia coli InfectionsAminoglycosidesGram-Positive CocciAzithromycinExtensively Drug-Resistant TuberculosisTherapeutic EquivalencyCapsulesParticle SizeLactamsRespiratory Tract InfectionsDrug UtilizationDrug Therapy, CombinationSolubilityClofazimineMinocyclineAmikacin